Insignis Therapeutics

North Haven, United States

Insignis Therapeutics is a drug development company that works with strategic partners to leverage their complementary resources.

$500K raised

Jun 2023

Venture - Series Unknown

Manufacturing Pharmaceutical Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Insignis Therapeutics

How much funding has Insignis Therapeutics raised?

Insignis Therapeutics has raised $500K in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2023.

Where is Insignis Therapeutics headquartered?

Insignis Therapeutics is headquartered in North Haven, United States.

What does Insignis Therapeutics do?

Insignis Therapeutics is a drug development company that works with strategic partners to leverage their complementary resources.

What stage is Insignis Therapeutics at?

Insignis Therapeutics is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated June 16, 2023.

MLA

"Insignis Therapeutics — Funding & Investors." VCBacked, June 16, 2023, https://www.vcbacked.co/company/insignis-therapeutics. Accessed July 3, 2026.

APA

VCBacked. (2023). Insignis Therapeutics — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/insignis-therapeutics

Wikipedia (cite web)

{{cite web |title=Insignis Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/insignis-therapeutics |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated June 16, 2023.